Authors
MD Magazine® Editorial Staff
Latest:
ARO-HBV Reduces All Measurable Viral Products in Patients with Chronic Hepatitis B Virus InfectionThe first results of a study on the use of monthly RNAi with ARO-HBV in patients with chronic hepatitis B virus infections indicate that the treatment effectively reduced all measurable viral products, including HBsAg.
MD Magazine® Staff
Latest:
FDA Approves Ubrogepant for Acute Migraine in AdultsThe oral CGRP antagonist becomes the first in its class approved for the indication.
By MD Magazine Staff
Latest:
Letermovir Important Regimen for CMV PreventionThe indication for letermovir represents a significant milestone, since CMV infection remains the most common complication of stem cell transplantation for patients with cancer.
